Newsfile Corp
13 Oct 2026, 19:53 UTC · 1h ago
AARD DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
Impact · against what's priced in
Aardvark Therapeutics faces potential legal headwinds as the deadline for lead plaintiff appointment in a securities class action occurs, focusing on alleged safety misrepresentations of ARD-101. While the existence of the lawsuit is likely known, the specific procedural deadline may slightly shift the risk profile for institutional holders.
- AARD−0.30
No priced-in read yet





